LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 269

Search options

  1. Article: [Challenges of screening germline predispositions in children].

    Manabe, Atsushi

    Rinsho ketsueki] The Japanese journal of clinical hematology

    2020  Volume 61, Issue 6, Page(s) 682–686

    Abstract: Genetic predisposition is a major cause of childhood cancer. Multiple cancer-predisposing syndromes have been identified, including Li-Fraumeni syndrome (LFS), neurofibromatosis type 1, APC-related adenomatous polyposis, Beckwith-Wiedemann syndrome, ... ...

    Abstract Genetic predisposition is a major cause of childhood cancer. Multiple cancer-predisposing syndromes have been identified, including Li-Fraumeni syndrome (LFS), neurofibromatosis type 1, APC-related adenomatous polyposis, Beckwith-Wiedemann syndrome, multiple endocrine neoplasia 1, ataxia telangiectasia, RUNX1 deficiency, Fanconi anemia, Bloom syndrome, and PTEN hamartoma tumor syndrome. LFS is a prototypical genetically predisposing condition. Accordingly, individualized therapy, surveillance, risk reduction, and family counseling are needed when a patient is diagnosed with LFS. More ethically important problems are encountered in a pediatric LFS patient, including the identification of patients requiring screening, the age at screening, the process of obtaining informed consent from children, and the responsibility of following a pediatric patient with a genetic predisposition. Therefore, it is crucial to determine whether planned genetic testing has direct benefits for pediatric patients. In this context, TP53 testing may be justified in a pediatric cancer patient with suspected LFS, given the importance of decisions such as the use of radiotherapy and the screening of family members as hematopoietic stem cell transplantation donors, the surveillance of subsequent cancers, and counseling for family members. In this review article, I have discussed these issues and indicated some consensus among various clinicians, including adult hematologists.
    MeSH term(s) Child ; Genetic Predisposition to Disease ; Genetic Testing ; Genotype ; Germ Cells ; Humans ; Li-Fraumeni Syndrome
    Language Japanese
    Publishing date 2020-07-06
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 390900-1
    ISSN 0485-1439
    ISSN 0485-1439
    DOI 10.11406/rinketsu.61.682
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Survey of Transitional Care Between Pediatrics and Obstetrics/Gynecology in Japan.

    Nakamura, Kentaro / Terashita, Yukayo / Manabe, Atsushi / Suzuki, Nao

    Journal of adolescent and young adult oncology

    2024  

    Abstract: Purpose: ...

    Abstract Purpose:
    Language English
    Publishing date 2024-02-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2607978-1
    ISSN 2156-535X ; 2156-5333
    ISSN (online) 2156-535X
    ISSN 2156-5333
    DOI 10.1089/jayao.2023.0017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].

    Hirabayashi, Shinsuke / Manabe, Atsushi / Ohki, Kentaro / Kiyokawa, Nobutaka

    Rinsho ketsueki] The Japanese journal of clinical hematology

    2023  Volume 64, Issue 7, Page(s) 633–638

    Abstract: B-cell precursor acute lymphoblastic leukemia (BCP-ALL) has many subtypes with diverse clinical and biological features and outcomes. Next generation sequencing has revealed several novel subtypes, including the ZNF384 and MEF2D rearrangements. The ... ...

    Abstract B-cell precursor acute lymphoblastic leukemia (BCP-ALL) has many subtypes with diverse clinical and biological features and outcomes. Next generation sequencing has revealed several novel subtypes, including the ZNF384 and MEF2D rearrangements. The clinical characteristics and outcomes of the largest series of BCP-ALL cases with ZNF384 and MEF2D rearrangements in an international collaborative study are described here. Patients with ZNF384 rearrangements appear to express various leukemic phenotypes, including BCP-ALL (with or without abnormal expression of myeloid markers) and B/myeloid mixed phenotype acute leukemia. We provide strong evidence that among BCP-ALL patients with a ZNF384 fusion, the partner gene is associated with demographic features and influences the outcome; particularly the EP300-ZNF384 fusion is associated with a low risk of relapse. MEF2D rearrangements have been primarily described in children and young adults with BCP-ALL. Previous research has suggested that patients with MEF2D-BCL9 fusion have a high risk of relapse. Despite having the MEF2D-HNRNPUL1 fusion gene, the prognosis was favorable. Improved diagnostic genomic testing will enable future prospective studies to clarify the clinical significance of the ZNF384 and MEF2D rearrangements in childhood and young adult BCP-ALL.
    MeSH term(s) Humans ; Prospective Studies ; Oncogene Proteins, Fusion/genetics ; Transcription Factors ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Burkitt Lymphoma ; Trans-Activators/genetics ; MEF2 Transcription Factors/genetics
    Chemical Substances Oncogene Proteins, Fusion ; Transcription Factors ; ZNF384 protein, human ; Trans-Activators ; MEF2D protein, human ; MEF2 Transcription Factors
    Language Japanese
    Publishing date 2023-05-09
    Publishing country Japan
    Document type English Abstract ; Journal Article
    ZDB-ID 390900-1
    ISSN 0485-1439
    ISSN 0485-1439
    DOI 10.11406/rinketsu.64.633
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Overview.

    Manabe, Atsushi

    Rinsho ketsueki] The Japanese journal of clinical hematology

    2016  Volume 57, Issue 7, Page(s) 881

    MeSH term(s) Hematologic Diseases ; Humans ; Periodicals as Topic
    Language Japanese
    Publishing date 2016
    Publishing country Japan
    Document type Introductory Journal Article
    ZDB-ID 390900-1
    ISSN 0485-1439
    ISSN 0485-1439
    DOI 10.11406/rinketsu.57.881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: From a paper-based to a web-based Journal.

    Manabe, Atsushi

    Pediatrics international : official journal of the Japan Pediatric Society

    2016  Volume 58, Issue 1, Page(s) 3

    MeSH term(s) Humans ; Internet ; Journal Impact Factor ; Pediatrics ; Periodicals as Topic
    Language English
    Publishing date 2016-01
    Publishing country Australia
    Document type Editorial
    ZDB-ID 1470376-2
    ISSN 1442-200X ; 1328-8067
    ISSN (online) 1442-200X
    ISSN 1328-8067
    DOI 10.1111/ped.12879
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?

    Manabe, Atsushi

    International journal of hematology

    2016  Volume 103, Issue 4, Page(s) 359

    MeSH term(s) Anemia, Aplastic/pathology ; Anemia, Aplastic/therapy ; Bone Marrow/pathology ; Bone Marrow Diseases/pathology ; Bone Marrow Diseases/therapy ; Child ; Hematopoietic Stem Cell Transplantation ; Hemoglobinuria, Paroxysmal/pathology ; Hemoglobinuria, Paroxysmal/therapy ; Humans ; Leukemia, Myeloid/pathology ; Leukemia, Myeloid/therapy ; Myelodysplastic Syndromes/pathology ; Myelodysplastic Syndromes/therapy
    Language English
    Publishing date 2016-04
    Publishing country Japan
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 1076875-0
    ISSN 1865-3774 ; 0917-1258 ; 0925-5710
    ISSN (online) 1865-3774
    ISSN 0917-1258 ; 0925-5710
    DOI 10.1007/s12185-016-1966-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus.

    Manabe, Atsushi / Sada, Ryuichi Minoda / Miyake, Hirofumi / Akebo, Hiroyuki / Tsugihashi, Yukio / Hatta, Kazuhiro

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 7750

    Abstract: Hydroxychloroquine (HCQ) use is indicated for patients with systemic lupus erythematosus (SLE). Nevertheless, reports discussing the reasons for not prescribing HCQ are limited. We identified the factors that interfere with HCQ use in patients with SLE. ... ...

    Abstract Hydroxychloroquine (HCQ) use is indicated for patients with systemic lupus erythematosus (SLE). Nevertheless, reports discussing the reasons for not prescribing HCQ are limited. We identified the factors that interfere with HCQ use in patients with SLE. This observational, single-center study included data from 265 patients with SLE in 2019. The patients were categorized into groups with and without a history of HCQ use. Between these groups, clinical characteristics were compared using univariate analysis and logistic regression models. Among the 265 patients, 133 (50.2%) had a history of HCQ use. Univariate analysis identified older age; longer disease duration; lower prednisolone dose, clinical SLE disease activity index 2000, and estimated glomerular filtration rate; higher C3 level; and lower anti-double-stranded DNA antibody concentration as HCQ non-use-related variables. Logistic regression models identified a positive association between HCQ non-use and longer disease duration (odds ratio [OR] 1.08), prednisolone dose ≤ 7.5 mg/day (OR 4.03), C3 level ≥ 73 mg/dL (OR 2.15), and attending physician having graduated > 10 years prior (OR 3.19). In conclusion, a longer disease duration, lower prednisolone dose, higher C3 level, and longer time since attending physicians' graduation correlated with HCQ non-use. Physicians and patients should be educated to facilitate HCQ use despite these factors.
    MeSH term(s) Humans ; Antirheumatic Agents/therapeutic use ; Hydroxychloroquine/therapeutic use ; Logistic Models ; Lupus Erythematosus, Systemic/complications ; Prednisolone/therapeutic use
    Chemical Substances Antirheumatic Agents ; Hydroxychloroquine (4QWG6N8QKH) ; Prednisolone (9PHQ9Y1OLM)
    Language English
    Publishing date 2024-04-02
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-58463-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Review article series on the state of recent evidence in childhood cancer.

    Manabe, Atsushi

    Pediatrics international : official journal of the Japan Pediatric Society

    2015  Volume 57, Issue 4, Page(s) 515

    MeSH term(s) Biomedical Research/methods ; Cause of Death/trends ; Child ; Combined Modality Therapy ; Early Detection of Cancer ; Global Health ; Humans ; Morbidity/trends ; Neoplasms/diagnosis ; Neoplasms/epidemiology ; Neoplasms/therapy ; Periodicals as Topic
    Language English
    Publishing date 2015-08
    Publishing country Australia
    Document type Editorial ; Review
    ZDB-ID 1470376-2
    ISSN 1442-200X ; 1328-8067
    ISSN (online) 1442-200X
    ISSN 1328-8067
    DOI 10.1111/ped.12746
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Hepatoblastoma with bone/bone marrow metastasis in Li-Fraumeni syndrome patient.

    Hasegawa, Masataka / Sugiyama, Minako / Terashita, Yukayo / Cho, Yuko / Manabe, Atsushi

    Pediatrics international : official journal of the Japan Pediatric Society

    2022  Volume 64, Issue 1, Page(s) e15135

    MeSH term(s) Bone Marrow Neoplasms/diagnosis ; Bone Neoplasms ; Hepatoblastoma/diagnosis ; Humans ; Li-Fraumeni Syndrome/complications ; Li-Fraumeni Syndrome/diagnosis ; Liver Neoplasms
    Language English
    Publishing date 2022-07-05
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 1470376-2
    ISSN 1442-200X ; 1328-8067
    ISSN (online) 1442-200X
    ISSN 1328-8067
    DOI 10.1111/ped.15135
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Therapeutic Drug Monitoring of Oral Voriconazole in an Infant Less than Six Months of Age and Pharmacokinetics Changes Induced by Development of CYP2C19 in the Growth Process: A Novel Case Report.

    Yamaguchi, Atsushi / Tazawa, Yuki / Ueki, Masashiro / Yamada, Masafumi / Manabe, Atsushi / Sugawara, Mitsuru / Takekuma, Yoh

    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

    2023  Volume 143, Issue 6, Page(s) 545–549

    Abstract: Therapeutic drug monitoring (TDM) is recommended for voriconazole (VRCZ) to avoid adverse events and maximize antifungal efficacy. Currently, the appropriate dose for patients under the age of 2 years is unknown. Here, we report the case of a 1.5-month- ... ...

    Abstract Therapeutic drug monitoring (TDM) is recommended for voriconazole (VRCZ) to avoid adverse events and maximize antifungal efficacy. Currently, the appropriate dose for patients under the age of 2 years is unknown. Here, we report the case of a 1.5-month-old infant with inborn errors of immunity who was orally administered VRCZ. This patient's plasma concentration decreased significantly from 3.8 µg/mL (day 6) to 0.09 µg/mL (day 21), leading to repeated dose escalations to achieve the target concentration (1.38 µg/mL, day 58). The signal intensity ratio of VRCZ to its main metabolite, N-oxide VRCZ, in LC/MS/MS also decreased from 5.30 (day 6) to 0.57 (day 64). Consequently, we suspected that VRCZ metabolism may be enhanced during infant growth. To our knowledge, this is the first report of remarkable changes in VRCZ pharmacokinetics with metabolic activity enhanced by the growth process. In conclusion, we propose that frequent TDM helped to maintain adequate VRCZ plasma concentration in a infants less than 6 months of age.
    MeSH term(s) Humans ; Infant ; Antifungal Agents ; Cytochrome P-450 CYP2C19 ; Drug Monitoring ; Tandem Mass Spectrometry ; Voriconazole/pharmacology ; Voriconazole/therapeutic use
    Chemical Substances Antifungal Agents ; CYP2C19 protein, human (EC 1.14.14.1) ; Cytochrome P-450 CYP2C19 (EC 1.14.14.1) ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2023-05-29
    Publishing country Japan
    Document type Case Reports ; Journal Article
    ZDB-ID 200514-1
    ISSN 1347-5231 ; 0031-6903 ; 0372-7750 ; 0919-2085 ; 0919-2131
    ISSN (online) 1347-5231
    ISSN 0031-6903 ; 0372-7750 ; 0919-2085 ; 0919-2131
    DOI 10.1248/yakushi.23-00001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top